Hypercholesterolemia - Is lipid-lowering worthwhile for older patients

被引：0
|
作者：
Deedwania, PC [1 ]
机构：
[1] VA Cent Calif Hlth Care Syst, Fresno, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
来源：
GERIATRICS-US | 2000年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Despite some indications to the contrary, evidence continues to accumulate that controlling cholesterol levels with drug therapy in older persons is a worthwhile goal. Older persons with hypercholesterolemia have an elevated risk of coronary heart disease morbidity and mortality, and this risk increases as they age. Recent clinical trials have suggested that older persons benefit from lipid-lowering therapy as much as younger patients do. Therefore, intervention appears to be justified-as is greater vigilance in identifying untreated patients.
引用
收藏
页码：22 / +
页数：8
相关论文
共 50 条
  • [31] CORONARY ARTERY CALCIUM IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA RECEIVING STANDARD LIPID-LOWERING THERAPY
    Sheth, Samip
    Rader, Daniel
    Jacoby, Douglas
    CLINICAL CARDIOLOGY, 2019, 42 : S39 - S39
  • [32] The development and psychometric analysis of a lipid-lowering therapy quality of life scale for patients with hypercholesterolemia
    Coombs, VJ
    Berk, RA
    Allen, JK
    CIRCULATION, 2004, 110 (17) : 665 - 665
  • [33] Lipid-lowering effect of 2 dosages of a soy protein supplement in Hypercholesterolemia
    Lars H. Høie
    Hans-Joachim Graubaum
    Andrea Harde
    Joerg Gruenwald
    Klaus-D. Wernecke
    Advances in Therapy, 2005, 22 : 175 - 186
  • [34] The Role of Non-statin Lipid-Lowering Medications in Youth with Hypercholesterolemia
    Waleed Z. Butt
    Jennifer K. Yee
    Current Atherosclerosis Reports, 2022, 24 : 379 - 389
  • [35] Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
    Perez-Calahorra, Sofia
    Laclaustra, Martin
    Marco-Benedi, Victoria
    Lamiquiz-Moneo, Itziar
    Pedro-Botet, Juan
    Plana, Nuria
    Sanchez-Hernandez, Rosa M.
    Amor, Antonio J.
    Almagro, Fatima
    Fuentes, Francisco
    Suarez-Tembra, Manuel
    Civeira, Fernando
    ATHEROSCLEROSIS, 2019, 284 : 245 - 252
  • [36] NUMBER OF LIPID-LOWERING MEDICATIONS AND ATTAINMENT OF LIPID GOALS IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: DATA FROM THE LATVIAN REGISTRY
    Nesterovics, G.
    Saripo, V.
    Meiere, R.
    Terauda, E.
    Skudrina, G.
    Gilis, D.
    Erglis, A.
    Latkovskis, G.
    ATHEROSCLEROSIS, 2022, 355 : E176 - E176
  • [37] Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia
    Izar, M. C.
    Machado, V. A.
    Fonseca, H. A.
    Fonseca, F. A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 285 - 285
  • [38] Rapid lipid-lowering response in two cases of autosomal recessive hypercholesterolemia
    Yazici, Havva
    Erdem, Fehime
    Canda, Ebru
    Ucar, Sema Kalkan
    Coker, Mahmut
    JOURNAL OF CLINICAL LIPIDOLOGY, 2025, 19 (01) : 167 - 172
  • [39] Is aggressive lipid-lowering effective and safe in the older adult?
    LaRosa, JC
    CLINICAL CARDIOLOGY, 2005, 28 (09) : 404 - 407
  • [40] EFFECTS OF PHYTOSTEROL SUPPLEMENTATION TO THE MAXIMUM LIPID-LOWERING THERAPY IN FAMILIAL HYPERCHOLESTEROLEMIA
    Matos, Livia N.
    Machado, Valeria A.
    Barbosa, Silvio A.
    Fonseca, Marilia I.
    Fonseca, Francisco A.
    Borges, Ney C.
    Izar, Maria C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1464 - E1464
12345